Clinical trials
Overweight or Obese clinical trials
Below are recruiting overweight or obese clinical trials, each written for real people, not researchers. We’re tracking 1,472 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07217756Recruiting
How weight affects braces treatment in teens
This study looks at how having a higher BMI (body mass index) affects treatment with braces during the teenage years. It will compare results between teens with normal weight and those who are overweight to see if there are any differences in how long or how well braces work.
Rochester, New YorkAges 12–18 - NCT07209527Enrolling by invitationEarly Phase 1
Truway diagnostic tools in primary care
This trial tests new diagnostic tools that doctors can use in primary care. Researchers want to see if these tools help find the right diagnosis faster and more accurately.
New York, New YorkAges Any age - NCT06859853RecruitingPhase 1
MWN109 injection safety study in healthy volunteers
This trial tests an investigational injection called MWN109 to see if it is safe and how the body processes it. It is for healthy adults only, and the results will help decide if the drug should be tested in people with medical conditions.
Melbourne, VictoriaAges 18–50 - NCT07202884RecruitingPhase 3
Orforglipron for Women with Stress Incontinence and Overweight
This study tests an oral medication called orforglipron to see if it helps women with stress urinary incontinence who are also overweight or have obesity. The medicine may reduce leaking episodes and also help with weight loss.
Birmingham, AlabamaAges 18 years+ - NCT07199283Recruiting
Preventing future health problems after preeclampsia
This study looks at whether a simple treatment after childbirth can help prevent future health problems for women who had preeclampsia in their first pregnancy. You may be able to join if you are a first-time mom who had preeclampsia, you are 18 or older, and you have a smartphone.
Stockholm, Stockholm CountyAges 18 years+ - NCT07196852Recruiting
Exercise training and redox status study
This trial looks at how exercise training affects your body's natural antioxidant systems. It may be a good fit if you have a higher body mass index but are otherwise healthy and not taking any medications or supplements.
Trikala, KariesAges 30–45 - NCT07187830Recruiting
Semaglutide for belly fat and liver health in kidney disease
This study looks at whether semaglutide (a diabetes medication) affects belly fat and the liver in people who have both type 2 diabetes and chronic kidney disease. It aims to understand if the drug can improve these health markers even in patients with reduced kidney function.
Edmonton, AlbertaAges 18 years+ - NCT05309395RecruitingPhase 3
Food prescriptions to help Latino families eat affordably
This trial tests whether giving free/covered “food prescriptions” helps multigenerational Latino households lose weight by improving diet within a budget. It may help families who want to eat healthier without worrying as much about grocery costs.
Pasadena, CaliforniaAges 2 years+ - NCT07180368Recruiting
Managing multiple medications in older adults
This study looks at how to better manage multiple medications in older adults with long-term health conditions. It aims to improve safety and reduce drug-related problems.
Xi'an, ShaanxiAges 65 years+ - NCT07180316Recruiting
Comparing robotic vs. laparoscopic surgery for weight loss revision
This trial compares two types of surgery (robotic and laparoscopic) to see which leads to fewer problems after a second weight-loss operation. It is for people who need to revise their first bariatric surgery to a Roux-en-Y gastric bypass.
LyonAges 18–70 - NCT06935513Recruiting
Wearable devices for stroke prevention
This trial tests if using a smart wearable device can help people at high risk for stroke stay active and reduce their risk. You may be able to join if you have certain health conditions or habits that increase your stroke risk.
Nantong, JiangsuAges 30 years+ - NCT07171281Recruiting
Timing meals to improve blood sugar and heart health
This study tests whether eating at specific times of day can help control blood sugar and improve heart health in people with prediabetes or type 2 diabetes. It compares two different eating schedules to see which works better.
NuthetalAges 18–75 - NCT07150975RecruitingPhase 3
Study comparing new weekly injection vs. Wegovy for weight loss
This trial tests a new weekly injection called GZR18 against the existing drug Wegovy for weight loss in adults who are overweight or obese. It aims to see which is more effective and safe for helping people lose weight and improve related health conditions.
BeijingAges 18 years+ - NCT07140952Recruiting
Heart-healthy diet and exercise for stroke survivors
This study tests a heart-healthy diet and exercise plan for stroke survivors to improve health and fitness. It is done virtually to make it easy to join from home.
Florence, South CarolinaAges 45–80 - NCT07136714RecruitingPhase 4
Semaglutide for depression in people with overweight
This study tests whether a weekly injection of semaglutide (a medication used for weight loss and diabetes) can help reduce symptoms of depression in people who have major depressive disorder and are overweight or obese.
Hillerød, DenmarkAges 18–65 - NCT07128888RecruitingPhase 1
GZR18 injection effects on stomach emptying and drug interactions
This trial tests how a new injectable drug, GZR18, affects how fast your stomach empties and how it interacts with other medicines. It is for obese Chinese adults who want to join a research study.
BeijingAges 18–50 - NCT07134335RecruitingPhase 2
Study of UBT251 injection for chronic kidney disease
This study tests an investigational injection called UBT251 for people with chronic kidney disease who are overweight. It aims to see if it can reduce protein in the urine and help protect kidney function.
BeijingAges 18–75 - NCT07123779RecruitingPhase 1/Phase 2
Study of a new drug for heart failure with pulmonary hypertension
This study tests an investigational drug (HS235) for people who have both heart failure with preserved ejection fraction and a type of pulmonary hypertension that can happen with it. The goal is to see if the drug can improve symptoms and quality of life.
Kansas City, MissouriAges 18 years+ - NCT07118540Recruiting
Weight-loss surgery follow-up after 5 years
This trial is checking how well patients are cared for after weight-loss surgery, focusing on those who stopped coming to check-ups 5 years after their operation. If you were part of the OBESEPI study and haven't been seen recently, this research wants to understand your experience.
Nancy, LorraineAges 18–65 - NCT07114419RecruitingPhase 2
New weekly injection for weight loss in overweight or obesity
This study tests a new weekly injection, efsubaglutide alfa (a GLP-1 drug), for helping people with overweight or obesity lose weight. It is for people who have not been able to lose weight with diet and exercise alone and do not have other serious health conditions.
BrookvaleAges 18–75 - NCT07097506RecruitingPhase 2
Ketone drink for liver fat and health
This study tests whether a daily ketone ester drink can reduce liver fat and improve metabolism in people with excess liver fat. You may join if you are 18–40, have overweight or obesity, and your liver has extra fat.
St Louis, MissouriAges 18–40 - NCT07085923Recruiting
Heart health study for people with mental illness
This study tests a program to improve heart health in people with schizophrenia or bipolar disorder who take antipsychotic medication or lithium and have a high body weight. The goal is to help reduce heart disease risk.
OsloAges 25–70 - NCT07095543Recruiting
Plant-based weight loss through online program
This study tests an online weight loss program based on a plant-based diet. You may be able to join if you live in the U.S., are overweight, can travel to Washington DC for a body scan, and are not using weight loss medications.
Washington D.C., District of ColumbiaAges 18 years+ - NCT07086989Recruiting
Heart health study for kids with chronic conditions
This study looks at heart disease risk in children and young adults (ages 6-25) with long-term health conditions like certain heart, kidney, or diabetes disorders. The goal is to better understand and manage heart risks early.
BudapestAges 6–25
Hear when a new Overweight or Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for overweight or obese?
- Yes. Clin2 currently lists 1,472 recruiting overweight or obese studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a overweight or obese trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a overweight or obese trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.